Planmeca USA Revenue and Competitors

Roselle, IL USA

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Planmeca USA's estimated annual revenue is currently $108.2M per year.(i)
  • Planmeca USA's estimated revenue per employee is $251,000

Employee Data

  • Planmeca USA has 431 Employees.(i)
  • Planmeca USA grew their employee count by 11% last year.

Planmeca USA's People

NameTitleEmail/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$63.5M2536%N/AN/A
#2
$13.6M5410%N/AN/A
#3
$9.8M390%N/AN/A
#4
$1.5M6-60%N/AN/A
#5
$21.1M84-3%N/AN/A
#6
$38.4M153-1%N/AN/A
#7
$114.2M4554%N/AN/A
#8
$45.9M183-6%N/AN/A
#9
$12450M385121%$1.7BN/A
#10
$4.3M17-60%N/AN/A
Add Company

What Is Planmeca USA?

Our Mission: Provide better patient care through pioneering health care solutions that improve the daily workflow of dental and medical professionals around the world.

keywords:N/A

N/A

Total Funding

431

Number of Employees

$108.2M

Revenue (est)

11%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Planmeca USA News

2022-04-20 - Digital Intraoral Scanner Market Size, Outlook And Forecast ...

Planmeca USA, Luminous Dental Studio, 3shape, AlignTechnology, Carestream Dental, Dental Wings, Dentsply Sirona, Guangdong Launca Medical Device.

2022-04-20 - Digital Intraoral Scanner Market Size, Outlook And Forecast ...

Planmeca USA, Luminous Dental Studio, 3shape, AlignTechnology, Carestream Dental, Dental Wings, Dentsply Sirona, Guangdong Launca Medical Device.

2022-04-13 - Planmeca Ultra Low Dose Technology Scientifically Proven in ...

Planmeca USA is a subsidiary of Planmeca, the largest privately held company in the dental equipment market and one of the industry's...

2022-04-13 - Planmeca Ultra Low Dose Technology Scientifically Proven in ...

Planmeca USA is a subsidiary of Planmeca, the largest privately held company in the dental equipment market and one of the industry's...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$35M4450%N/A
#2
$210.9M47839%N/A
#3
$1265.7M36021%N/A